Valuation: JMS Co.,Ltd.

Market Cap 11.01B 70.06M 62.53M 57.69M 52.41M 98.33M 6.64B 99.84M 695M 274M 3.48B 263M 257M P/E 2025
127x
P/E 2026 -13.3x
Enterprise Value 31.3B 199M 178M 164M 149M 279M 18.86B 284M 1.97B 778M 9.88B 747M 731M EV / Sales 2025
0.43x
EV / Sales 2026 0.47x
Free-Float
64%
Yield 2025
3.69%
Yield 2026 4%
05-12 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Half Year Ending September 2026 and the Full Year Ending March 31, 2027 CI
05-12 JMS Co.,Ltd. Proposes Dividend for Fiscal Year Ended March 31, 2026, Payable on June 24, 2026; Provides Dividend Guidance for Second Quarter Ending September 2026 and Fiscal Year Ending March 31, 2027 CI
02-06 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026 CI
11-07 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 CI
11-07 JMS Co.,Ltd. Announces Dividend for the Second Quarter End of the Fiscal Year Ending March 31, 2026, Payable on December 10, 2025 CI
25-05-09 JMS Co.,Ltd. Announces Dividend for the Year Ended March 31, 2025, Payable on June 25, 2025; Provides Dividend Guidance for the Second Quarter and Year Ending March 31, 2026 CI
25-05-09 JMS Co.,Ltd. Provides Earnings Guidance for the Six Months Ending September 2025 and the Full Year Ending March 31, 2026 CI
25-02-07 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025 CI
24-11-07 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025 CI
24-11-07 JMS Co.,Ltd. Announces Dividend for the Second Quarter Period Ended September 2024, Payable on December 10, 2024 and Provides Dividend Guidance for the Year Ending March 31, 2025 CI
24-05-14 JMS Co.,Ltd. Provides Earnings Guidance for the Six Months Ending September 2024 and the Full Year Ending March 31, 2025 CI
24-05-14 Jms Co.,Ltd. Announces Dividend for the Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the Second Quarter Ending September 2024 and Year Ending March 31, 2025 CI
23-11-07 JMS Co.,Ltd. Announces Dividend for the Second Quarter ended September 2023 Payable on December 8, 2023; Provides Guidance for the Year End for the Year March 31, 2024 CI
1 day-0.66%
1 week+1.58%
Current month-1.10%
1 month-2.18%
3 months-4.67%
6 months+3.70%
Current year+1.58%
1 week 441
Extreme 441
454
1 month 439
Extreme 439
463
Current year 418
Extreme 418
478
1 year 418
Extreme 418
478
3 years 405
Extreme 405
549
5 years 405
Extreme 405
778
10 years 405
Extreme 405
1,198
Manager TitleAgeSince
Director of Finance/CFO 63 2007-06-30
Chief Tech/Sci/R&D Officer 59 2023-05-31
Corporate Officer/Principal 59 2012-03-31
Director TitleAgeSince
Chairman 71 2024-05-31
Director/Board Member 65 2011-05-31
Director/Board Member 70 2023-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+1.58%+1.35%-14.64% 70.15M
+1.99%-2.07%-19.88%+7.03% 174B
+3.19%+4.72%-20.93%+16.51% 114B
+3.83%+1.19%+0.72%+33.43% 114B
+1.93%+19.62%-44.05%+8.64% 89.64B
-0.57%-0.86%+2.32%+79.26% 64.96B
-0.47%+3.86%+15.10%+80.50% 56.09B
+3.13%+3.44%+6.54%-21.69% 52.94B
+2.40%+3.58%-10.57%+32.51% 43.6B
+3.43%+8.36%-4.02%-10.63% 32.77B
Average +1.74%+4.22%-7.34%+21.09% 74.2B
Weighted average by Cap. +2.03%+3.58%-12.08%+23.28%

Financials

2025 2026
Net sales 69.75B 444M 396M 365M 332M 623M 42.02B 632M 4.4B 1.73B 22.02B 1.67B 1.63B 65.84B 419M 374M 345M 313M 588M 39.67B 597M 4.15B 1.64B 20.78B 1.57B 1.54B
Net income 89M 566K 505K 466K 424K 795K 53.62M 807K 5.62M 2.21M 28.09M 2.12M 2.08M -783M -4.98M -4.45M -4.1M -3.73M -6.99M -472M -7.1M -49.41M -19.46M -247M -18.69M -18.29M
Net Debt 19.04B 121M 108M 99.72M 90.6M 170M 11.47B 173M 1.2B 473M 6.01B 455M 445M 20.28B 129M 115M 106M 96.53M 181M 12.22B 184M 1.28B 504M 6.4B 484M 474M
Projected Income Statement - Annual - JMS Co.,Ltd.
Logo JMS Co.,Ltd.
JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Company’s main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.
Employees
4,887
Date Price Change Volume
26-10-22 JP¥449.00 -0.66% 17,300
26-10-21 JP¥452.00 -0.22% 21,100
26-10-20 JP¥453.00 +1.57% 40,700
26-10-19 JP¥446.00 -0.67% 46,000
26-10-16 JP¥449.00 +1.35% 23,700

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - JMS Co.,Ltd.
  1. Stock Market
  2. Stocks
  3. 7702 Stock